Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10621810rdf:typepubmed:Citationlld:pubmed
pubmed-article:10621810lifeskim:mentionsumls-concept:C0025678lld:lifeskim
pubmed-article:10621810lifeskim:mentionsumls-concept:C1442464lld:lifeskim
pubmed-article:10621810pubmed:issue8lld:pubmed
pubmed-article:10621810pubmed:dateCreated2000-1-13lld:pubmed
pubmed-article:10621810pubmed:abstractTextLevomepromazine (previously known as methotrimeprazine) has a broad range of beneficial effects in the terminal phase of many illnesses, resulting from its combined antipsychotic, anxiolytic and sedative actions. Levomepromazine can safely be administered in a continuous subcutaneous infusion with most other commonly used drugs in palliative care.lld:pubmed
pubmed-article:10621810pubmed:languageenglld:pubmed
pubmed-article:10621810pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10621810pubmed:citationSubsetIMlld:pubmed
pubmed-article:10621810pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10621810pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10621810pubmed:statusMEDLINElld:pubmed
pubmed-article:10621810pubmed:monthAuglld:pubmed
pubmed-article:10621810pubmed:issn1462-3935lld:pubmed
pubmed-article:10621810pubmed:authorpubmed-author:O'NeillJJlld:pubmed
pubmed-article:10621810pubmed:authorpubmed-author:FountainAAlld:pubmed
pubmed-article:10621810pubmed:issnTypePrintlld:pubmed
pubmed-article:10621810pubmed:volume60lld:pubmed
pubmed-article:10621810pubmed:ownerNLMlld:pubmed
pubmed-article:10621810pubmed:authorsCompleteYlld:pubmed
pubmed-article:10621810pubmed:pagination564-7lld:pubmed
pubmed-article:10621810pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10621810pubmed:meshHeadingpubmed-meshheading:10621810...lld:pubmed
pubmed-article:10621810pubmed:meshHeadingpubmed-meshheading:10621810...lld:pubmed
pubmed-article:10621810pubmed:meshHeadingpubmed-meshheading:10621810...lld:pubmed
pubmed-article:10621810pubmed:meshHeadingpubmed-meshheading:10621810...lld:pubmed
pubmed-article:10621810pubmed:meshHeadingpubmed-meshheading:10621810...lld:pubmed
pubmed-article:10621810pubmed:meshHeadingpubmed-meshheading:10621810...lld:pubmed
pubmed-article:10621810pubmed:meshHeadingpubmed-meshheading:10621810...lld:pubmed
pubmed-article:10621810pubmed:year1999lld:pubmed
pubmed-article:10621810pubmed:articleTitleLevomepromazine (methotrimeprazine) and the last 48 hours.lld:pubmed
pubmed-article:10621810pubmed:affiliationDepartment of Adult and Elderly Medicine, Countess of Chester Hospital.lld:pubmed
pubmed-article:10621810pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10621810pubmed:publicationTypeReviewlld:pubmed
pubmed-article:10621810pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed